3D printing-biomimetic local stiff niche enhances glycolysis to boost PDAC cell stem-like phenotype via N6-methyladenosine-suppressed YAP1 mRNA decay.

3D 打印仿生局部刚性微环境通过 N6-甲基腺苷抑制 YAP1 mRNA 降解来增强糖酵解,从而促进 PDAC 细胞干细胞样表型

阅读:11
作者:Wu Di, Guan Xiaoqi, Yang Tao, Yan Jiashuai, Zhu Biwen, Zhou Junchao, Guo Yibing, Lu Yuhua
Cancer stem cells (CSCs), the primary source of therapy resistance in pancreatic ductal adenocarcinoma (PDAC), exist in a dynamic equilibrium through tumor microenvironment (TME)-driven plasticity. However, the stiffness heterogeneity of TME within PDAC functions on tumor cell stem-like phenotypes remains unclear. Bioinformatics, including Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis, of CSCs identified from spatial transcriptomic and single-cell datasets of PDAC lesions exhibited activated mechanical and glycolytic pathways. Detected by the nano-indenter, PDAC tissue exhibited significant stiffness heterogeneity (200-6000 Pa). Further, biomimetic local stiffness niches were engineered using the digital light-processing (DLP) 3D-printing technology and the desmoplastic bioink (gelatin methacrylate & hyaluronic acid methacrylate, GelMA&HAMA) encapsulating PDAC cells, which permits modulation of mechanical properties without altering the biochemical ligand density. Stemness markers (NANOG, OCT4), glycolysis genes (HK2, LDHA), YAP1, and N6-methyladenosine (m6A) regulators (METTL14, IGF2BP3) were evaluated via qRT-PCR and immunofluorescence. Functional assays of glycolysis and stem-like phenotype were also conducted. Dot blot, RNA stability assay, western blot, and RIP assay were exploited to clarify the level and the function of m6A modification. The local stiff niche enhanced the stem-like phenotype of PDAC cells via YAP1-boosted glycolysis. Mechanistically, local stiff niche elevated the YAP1 level via m6A (METTL14/IGF2BP3)-stabilized YAP1 mRNA, linking mechanical inputs to glycolytic-stem-like phenotype adaptations. Collectively, the local stiff niches may drive the emergence of CSCs through epigenetic and metabolic reprogramming in PDAC mechanobiology. This provides new insights for developing more precise therapeutic strategies targeting PDAC mechanical heterogeneity.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。